Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05736848 · ClinicalTrials.gov registry record
A Retrospective Assessment of OviTex PRS (OviTex)
A clinical trial of Reconstructive Surgical Procedures, sponsored by Tela Bio.
- Recruiting
- Registry status
- 200
- Enrollment target
- 11
- Study locations
NCT05736848: Recruiting study of Reconstructive Surgical Procedures, sponsored by Tela Bio.
NCT05736848 is a study of Reconstructive Surgical Procedures that is actively recruiting participants, run by Tela Bio. The registered enrollment target is 200 participants. The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05736848, a study of Reconstructive Surgical Procedures, is actively recruiting participants, sponsored by Tela Bio.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 11
- Study locations
Study Summary
The objective of this retrospective-prospective, observational study is to evaluate the safety profile overall and within two device types of OviTex PRS in previous pre-pectoral or sub-pectoral implant-based breast reconstructions.
Primary Outcome
Retrospective - Prospective assessment
Conditions Studied
Interventions
- DEVICE OviTex® PRS
Study Locations (11)
Florida
- Aesthetic Surgery Center - Naples
- Castrellon Aesthetic Surgery - South Miami
New Jersey
- David L. Abramson, MD - Englewood
- Capital Health - Pennington
Texas
- Dermatology Associates of San Antonio/Baptist Medical Center - San Antonio
- Houston Methodist The Woodlands Hospital - The Woodlands
Georgia
- Y Plastic Surgery - Alpharetta
Massachusetts
- Massachusetts General Hospital - Boston
Michigan
- Janineh Plastic Surgery - Rochester Hills
New York
- Strong Memorial Hospital - Rochester
South Carolina
- Plastic Surgery Consultants - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-09-27 |
| Est. Completion | 2026-12-31 |
What NCT05736848 shows while recruiting
NCT05736848 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Reconstructive Surgical Procedures appearing as the primary indexed condition, and to 1 intervention - of which OviTex® PRS is the first listed.
NCT05736848 lists 11 locations in 8 states (Florida, New Jersey, Texas).
Frequently Asked Questions
What is clinical trial NCT05736848 about?
NCT05736848 is a clinical study titled "A Retrospective Assessment of OviTex PRS (OviTex)". The objective of this retrospective-prospective, observational study is to evaluate the safety profile overall and within two device types of OviTex PRS in previous pre-pectoral or sub-pectoral implant-based breast reconstructions.
What is the current status of trial NCT05736848?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-09-27. Estimated completion is 2026-12-31.
What conditions does trial NCT05736848 study?
This clinical trial studies the following conditions: Reconstructive Surgical Procedures.
What interventions are being tested in trial NCT05736848?
The interventions under investigation include: OviTex® PRS (DEVICE).
Who is sponsoring clinical trial NCT05736848?
This trial is sponsored by Tela Bio, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05736848 being conducted?
This trial has 11 study locations across Florida, Georgia, Massachusetts, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI